Mar 31, 2010 | Laboratory News, Laboratory Pathology
Pathology labs would generally benefit if Judge Sweet’s ruling is upheld on appeal It was positive news for many clinical pathology laboratories when a judge ruled against Myriad Genetics and the University of Utah Research Foundation in the federal suit attacking its patents for the BRCA1 and BRCA2 genes. The suit was brought by a group of patients, medical organizations and the American Civil Liberties Union (ACLU). In Association for Molecular Pathology, et al v. U.S. Patent and Trademark...
